On November 14th, representatives of the EIT Health visited Fraunhofer AICOS and had the opportunity to get to know the activity and work of the research centre, operated by Fraunhofer Portugal.
EIT Health is currently in Portugal carrying out several national prospecting actions to evaluate the innovation potential of the North Region, in the scope of the RIS programme in partnership with the University of Porto. Fraunhofer AICOS, being an institution of reference in the innovation area, was included in the delegation's tour. Koen Verhoef (Manager Technology Transfer Office at the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital), and Mark Wilson (experienced business and venture development professional and former Senior Director for Technology Licensing at GSK), visited AICOS, spoke with our researchers, and got to know some of the applied research work developed by AICOS in the innovation theme of Decentralised Health Technology.
The highlight of the visit was the Decentralised Health Technology, a vision that approaches Healthcare as an ecosystem where technology can ease the human intervention, the connection, and the collaboration. AICOS’ research in the field Decentralised Health Technology has the major goal of to improve the diseases prevention, the support to early diagnosis and intervention, and the development of affordable cutting-edge technology.
Coordinated internationally by the European Union, the EIT Health is a network of health innovators that collaborate across borders to deliver new solutions that enable European citizens to live longer and healthier lives. In February this year, EIT Health published a call for organisations to cooperate with the organisation as EIT Health hubs within the EIT Regional Innovation Scheme (RIS) 2018. University of Porto is one of seven new Hubs chosen from amongst companies, universities and institutes to cooperate with EIT Health in implementing the RIS programme in 2018 and developing the local innovation ecosystem.